Question

What is the recovery time after stem cell therapy for Lupus (SLE)?

A commercial infusion and HSCT have radically different recovery and immune risks. Follow the exact protocol; fever, chest pain, breathing difficulty, neurological change or signs of kidney deterioration require prompt medical assessment.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

What the evidence shows for Lupus (SLE)

Standard care is tailored to organ involvement and may include antimalarial, immunosuppressive, biologic and supportive treatment. HSCT and newer cellular immune approaches have been studied mainly in selected severe or refractory disease and can involve substantial toxicity. MSC evidence remains investigational and heterogeneous. The NIAMS lupus treatment guide should be used to compare established care; evidence from one cellular platform cannot validate another.

Am I a candidate? → · Lupus (SLE): full overview → · Lupus (SLE) cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information